Stuart A. Arbuckle, EVP, COO at VERTEX PHARMACEUTICALS INC / MA (VRTX), sold 19,136 shares at $298.42 ($5.7M) on 2023-02-13, disclosed to the SEC on 2023-02-14.
Seasonal sale ($5.7M) by EVP, COO — this insider has traded VRTX in February in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $294.33 | 3,372 | $992K | 17.4% |
| 2 | $296.44 | 245 | $73K | 1.3% |
| 3 | $296.44 | 245 | $73K | 1.3% |
| 4 | $298.26 | 5,990 | $1.8M | 31.3% |
| 5 | $298.42 | 2,028 | $605K | 10.6% |
| 6 | $298.42 | 2,028 |
| $605K |
| 10.6% |
| 7 | $299.26 | 1,779 | $532K | 9.3% |
| 8 | $299.26 | 1,779 | $532K | 9.3% |
| 9 | $300.13 | 835 | $251K | 4.4% |
| 10 | $300.13 | 835 | $251K | 4.4% |
| Total | $297.90 avg | 19,136 | $5.7M | 100% |
| Filing → |
| VRTX | SELL | 2024-02-23 | $3.0M | — | Filing → |
| VRTX | SELL | 2024-02-21 | $4.0M | — | Filing → |
| VRTX | SELL | 2024-02-13 | $3.6M | — | Filing → |